Unidus Corp. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
24,702
18,262
17,443
15,335
14,931
Cost of Goods Sold (COGS) incl. D&A
21,054
16,768
16,397
14,057
13,530
Gross Income
3,649
1,493
1,046
1,277
1,401
SG&A Expense
2,731
2,466
2,444
2,251
2,807
EBIT
846
1,055
1,538
1,059
1,542
Unusual Expense
337
48
12
35
-
Non Operating Income/Expense
258
78
242
105
127
Interest Expense
60
46
46
34
42
Pretax Income
345
1,069
1,656
1,030
1,423
Income Tax
266
172
82
32
1
Consolidated Net Income
79
897
1,574
1,063
1,421
Net Income
79
897
1,574
1,063
1,421
Net Income After Extraordinaries
79
897
1,574
1,063
1,421
Net Income Available to Common
79
897
1,574
1,063
1,421
EPS (Basic)
9.00
104.00
183.00
124.00
165.00
Basic Shares Outstanding
9
9
9
9
9
EPS (Diluted)
9.14
104.34
183.04
123.58
165.25
Diluted Shares Outstanding
9
9
9
9
9
EBITDA
1,918
70
619
298
881
Other Operating Expense
72
83
141
85
136
Non-Operating Interest Income
154
157
182
202
288

About Unidus

View Profile
Address
473-3 Gwangjang-ro
Jeungpyeong-gun NC 27908
Korea, Republic Of
Employees -
Website http://www.unidusok.com
Updated 09/14/2018
BioGenetics Co., Ltd. engages in the manufacture of rubber and latex products. It operates though the following business divisions: Condom, Cot, Glove and Plant. The condom business division provides differentiated condoms in thickness, design, and color at preferences.